Health Catalyst, Inc.
Company Stats
- Market Cap
- $130.2M
- as of Sep 30, 2026
- Enterprise Value
- $240.1M
- Shares Outstanding
- 75.3M
- Free Float
- 52.2%
Income Statement
- Revenue
- $311.1M
- Operating Income
- -$160.9M
- Net Income
- -$178.0M
- EBITDA
- -$145.9M
- Non-cash Impairment
- $105.4M
- Revenue Growth, 3Y
- 4.0%
- FCF Margin, 3Y Avg
- -2.5%
- FCF Margin, Worst Year
- -11.6%
Cash Flow
- Free Cash Flow
- -$237,000
- FCF Yield
- -0.2%
- Owner FCF Yield
- -20.9%
Balance Sheet
- Cash & Equivalents
- $50.8M
- Total Debt
- $160.8M
- Net Debt
- $109.9M
Returns & Capital
- Share Repurchases
- $5.0M
- Buyback Yield, 3Y Avg
- 1.7%
- SBC, 3Y Avg
- $41.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $311.1M | -$237,000 | -0.1% |
| FY2024 | $306.6M | $12.9M | 4.2% |
| FY2023 | $295.9M | -$34.3M | -11.6% |
| FY2022 | $276.2M | -$37.4M | -13.6% |
| FY2021 | $241.9M | -$33.6M | -13.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 1, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Aci Lifts 2026 Guidance as Software Demand Stays Positive
Stronger demand supports expansion as pricing diverges